LifeEdit Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
LifeEdit Therapeutics, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include LIFEEDIT and LIFE EDIT. The owner is based in Durham, NC.
300 Morris Street, Suite 300
Durham, NC 27701
Showing of trademarks Trademarks
Trademark Classifications
LifeEdit Therapeutics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does LifeEdit Therapeutics, Inc. have?
LifeEdit Therapeutics, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does LifeEdit Therapeutics, Inc. file in?
LifeEdit Therapeutics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are LifeEdit Therapeutics, Inc.'s most well-known trademarks?
LifeEdit Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as LIFEEDIT and LIFE EDIT. These are among 3 currently registered trademarks in the portfolio.
What is LifeEdit Therapeutics, Inc.'s trademark registration success rate?
LifeEdit Therapeutics, Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.